Introduction
============

Fat accumulation in bovine adipose tissues is the result of combined adipocyte hyperplasia and hypertrophy. However, Robelin[@b1-grsb-2010-091] showed that 70% of fat accumulation during postnatal growth is due to an increase in adipocyte hypertrophy alone. Fatty acids used for fat accumulation and adipocyte hypertrophy originate from either *de novo* fatty acid synthesis or dietary sources. In rodents, dietary polyunsaturated fatty acids (PUFA; both omega-6 and omega-3) are potent inhibitors of hepatic *de novo* lipogenesis.[@b2-grsb-2010-091]--[@b4-grsb-2010-091] Jeffcoat and James[@b2-grsb-2010-091] reported that supplementing corn oil to weanling rats at levels from 0.5 to 10% of diet (w/w) reduced FASN activity to about 30% of the level for a fat-free diet. Further studies showed diets rich in PUFA fed to adult and weanling rats reduced hepatic abundance of FASN message by 2-fold[@b3-grsb-2010-091] and 5.8-fold.[@b4-grsb-2010-091] The majority of research to date examining changes in lipogenic gene expression and dietary factors regulating gene expression has been conducted in rodents; however, several differences exist among murine and bovine lipogenesis including location of and primary substrate utilized for fatty acid synthesis.[@b5-grsb-2010-091]--[@b8-grsb-2010-091] Therefore, our objective was to examine changes in expression of genes involved in lipogenesis (LPL, ACC, FASN, and SCD) and proposed transcription factors or co-activators (PPARγ, C/EBPα, NF-Y, STAT5, Spot-14, SREBP1) in bovine adipose tissues from animals supplemented with increasing levels corn oil (57% C18:2 n-6).

Materials and Methods
=====================

Eighteen Angus steers (438 ± 4 kg body weight) were randomly assigned to 1 of 3 supplementation treatments. The 3 treatments consisted of 3 corn oil (57% linoleic acid, 28% oleic acid; 11% palmitic acid) supplementation levels: 0 (**NONE**), 0.31 kg/d (**MED**) and 0.62 kg/d (**HI**). Pelleted cottonseed hulls were used as a carrier for the oil supplement and were fed at equal amounts to all steers regardless of treatment throughout the experiment. Additional information on dietary conditions and animal performance are available in Pavan et al (2007).[@b9-grsb-2010-091] After 116 d on treatment, animals were euthanized and a sample of subcutaneous fat from the tail head region was removed from each carcass. Approximately, 10 g of subcutaneous fat was immediately frozen in liquid nitrogen and stored at −80 °C for subsequent RNA extraction.

Initial attempts to isolate high quality RNA from subcutaneous adipose tissue using TRIzol (Invitrogen, Town, CA) procedure found low 260/280 ratios (≤1.6) and yields (\<10 ug/g). Therefore, we developed a method ([Table 1](#t1-grsb-2010-091){ref-type="table"}) that would yield high quality RNA in appropriate amounts for qRT-PCR and microarray from subcutaneous adipose tissue. Snapfrozen adipose samples (2 g) were homogenized in 5 vol of TRIzol and centrifuged at 2600 *x g,* 2 °C for 30 min. to remove cellular debri and excess lipid. Chloroform (0.2 ml/ml of TRIzol used) was added, mixed, and centrifuged at 2600 *x g,* 2 °C for 30 min. Isopropanol (0.57x vol of aqueous layer) was added to the clear aqueous layer, and this phase was added to PureYield™ RNA Midiprep columns (Promega, Madison, WI). RNA purification was used completed following the manufacturer's directions. tcRNA was quantified using Quant-iT™ RiboGreen RNA Reagent (Invitrogen, Town, CA). Integrity of the isolated RNAs was confirmed by visualization of 18S and 28S ribosomal bands of individual samples subjected to denaturing slab gel electrophoresis in 1.2% agarose gel and 260/280 absorbance ratios. All tcRNA samples used in qRT-PCR analysis exhibited 260/280 ratios of \>1.8 and RNA yield averaged 32 ug/g adipose tissue.

For microarray analysis, tcRNA was pooled by treatment for NONE and HI on an equal weight basis for all individual samples in a treatment group. The Affymetrix GeneChip Bovine Genome array was used for hybridization of the extracted mRNAs according to the Affymetrix protocol at Medical College of Georgia, Genomics facility. Four GeneChips were analyzed per treatment group. The GeneChip Bovine Genome Array contained 24,027 probe sets, representing over 23,000 transcripts. The array was scanned and the gene expression data was generated using the Affymetrix software. Statistical analysis was performed for each gene separately using the following simple linear model: *y~ijk~* = *μ~i~* + *T~ij~* + *e~ijk~*, where *y~ijk~* is the base-2 logarithm of background adjusted and normalized average difference of signal intensity for gene *i*; *μ~i~* is the overall mean expression of gene *i*, *T~ij~* is dietary supplement *j*(*j* = 1,2) on gene *i*, and *e~ijk~* is the residual term. F-ratios were computed for all possible contrasts between the treatment levels using the contrast statement in SAS. In order to control experiment wise error rates, a false discovery rate (FDR) criteria was employed. The Benjamini Hochberg method[@b10-grsb-2010-091] was used to identify genes differentially expressed at a given FDR level. The process is summarized in the following steps: 1) after selecting a significance level, α~e~, genes were sorted by *P*-values from the most to the least significant, 2) threshold values were calculated for each test as: threshold*~i~* = i\**α~e~/R* for i = 1 to R, where R is the total number of tests (also the total number of genes) and i is the sorted position of the test, 3) each *P*-value was then compared to its respective threshold, starting with the most significant *P*-value, until a *P*-value greater than the threshold value was encountered. All following contrast was then considered to be insignificant. For this study an FDR of 0.05 was used to identify potentially differentially expressed genes. Least square estimates of both treatments for each single gene was calculated using the LSMEANS statement of SAS. The fold-change for each gene was calculated by taking the ratio of the least square estimates for all the two treatment comparisons to determine the magnitude of change in gene activity corresponding to each diet supplement.

PCR primers that span intron/exon junctions were designed using Primer3 software. Primer sequences for both end-point and real time quantitative PCR efficiencies are presented in [Table 2](#t2-grsb-2010-091){ref-type="table"}. Primer sets were evaluated first by using end-point PCR. Pooled tcRNA (1 ug) was reverse-transcribed in a 20 ul reaction volume using oligo dT and SuperScript™ III reverse transcriptase (Invitrogen) in a 2-step RT-PCR reaction. PCR was conducted using GoTaq (Promega) and 100 pM of each respective primer. Products were subjected to slab gel electrophoresis and visualized by ethidium bromide staining and fluorescence. Further all products were purified and subjected to di-deoxy sequencing at the Clemson University Genomics Institute to verify identity. For primer efficiency, a standard curve based on the original mass of tcRNA in the RT reaction was generated (50, 10, 2, 0.4, 0.08, and 0.016 ng per reaction) ran in triplicate, and subjected to qPCR by using the QuantiTect^®^ SYBR^®^ Green PCR kit (Qiagen) on an Eppendorf^®^ Mastercycler ^®^ ep realplex (Eppendorf). Primer efficiency was calculated by regression analyses using the Eppendorf Mastercycler Software and all efficiencies were between 0.85--1.07. For all qPCR conducted the thermal cycling conditions included: DNA polymerase activation at 95 °C for 15 min., 40 PCR cycles for 15s at 94 °C, 30s at 60 °C, and 30s at 72 °C in the presence of 100 nM of each primer combination.

For real time quantitative PCR (qPCR), 1 μg of tcRNA per steer was reverse transcribed (RT) and 2 ng of RT reaction subjected to qPCR by using the QuantiTect^®^ SYBR^®^ Green PCR kit (Qiagen) on an Eppendorf ^®^ Mastercycler^®^ ep realplex (Eppendorf). Each 96-well plate with all samples, primer set of interest, and housekeeping gene was replicated. For all qPCR conducted the thermal cycling conditions included: DNA polymerase activation at 95 °C for 15 min., 40 PCR cycles for 15s at 94 °C, 30s at 60 °C, and 30s at 72 °C in the presence of 100 pM of each primer combination. Melting curves were generated at the conclusion of amplification to verify presence of a single product. Two genes, GAPDH and β-actin, were evaluated as housekeeping genes for data normalization. To determine the appropriate housekeeping gene to be used to normalize the data, the C~T~ for GAPDH and β-actin, and all target genes per sample were entered into the BESTKEEPER program (<http://www.gene-quantification.info/>). The program determines the most stable housekeeping gene to be used for normalization by repeated pair-wise correlation analysis. Both GAPDH and β-actin in the analysis exhibited a coefficient of correlation of 0.99 (*P* \< 0.001) and would be suitable for data normalization.

The transcript levels for each gene were calculated at cycle threshold values (C~T~) at which each fluorescent signal was first detected above background. For the analysis of relative gene expression, all C~T~ values for each sample/primer pair combination and the respective primer efficiency were analyzed using the REST-2008 program (<http://www.gene-quantification.de/rest-2008.html>) for analysis and data normalized using GAPDH. The software calculates relative gene expression using Pair-wise Fixed Reallocation Randomization Test and relative expression determined at the 95% confidence interval. The fold-change in gene expression for MED or HI versus NONE were calculated using X^−ΔΔCT^ method if upregulated or −1 divided by X^−ΔΔCT^ if downregulated, where X = primer efficiency for each gene of interest, according to Pfaffl et al (2002)[@b11-grsb-2010-091] and these results are presented in the manuscript.

Results
=======

RNA quality and yield from the TRIzol procedure without clean up were unacceptable for qRT-PCR or microarray analysis. After development of a new method for RNA extraction from high fat, subcutaneous adipose tissues ([Table 1](#t1-grsb-2010-091){ref-type="table"}), all tcRNA samples used in these analyses exhibited 260/280 ratios of \>1.8 and RNA yield averaged 32 μg/g adipose tissue (range of 15--50 ug/g).

Results from the Affymetrix GeneChip Bovine Genome array show that several genes involved in lipogenesis were altered with omega-6 fatty acid supplementation ([Table 3](#t3-grsb-2010-091){ref-type="table"}). Carnitine palmitoytransferase II, fatty acid synthase (FASN), isocitrate dehydrogenase 1, hormone-sensitive lipase, glycerol-3-phosphate acyltransferase, diacylglycerol O-acyltransferase, 1-acylglycerol-3-phosphate O-acyltransferase 1, signal transducer and activator of transcription 5B (STAT5), and stearoyl-CoA desaturase (SCD) were all down regulated (*P* \< 0.05) with HI levels of oil supplementation compared to NONE. Expression of CCAAT/enhancer binding protein (C/EBPα), C/EBPΔ, isocitrate dehydrogenase 3, lipoprotein lipase (LPL), long-chain fatty acid acyl elongase, and peroxisome proliferators activated receptor γ (PPARγ) mRNA were up-regulated (*P* \< 0.05) with HI oil supplementation compared to NONE. Additional genes associated with fatty acid synthesis and metabolism that were identified to be differentially expressed in subcutaneous adipose tissues from steers supplemented with HI corn oil levels compared to NONE is shown in [supplementary Table 1](#t6-grsb-2010-091){ref-type="supplementary-material"}.

For qPCR analyses, expression of SCD mRNA was biomodal being up regulated (*P* \< 0.05) in the MED group and down regulated (*P* \< 0.05) in the HI group compared to NONE ([Table 4](#t4-grsb-2010-091){ref-type="table"}; [Figs. 1](#f1-grsb-2010-091){ref-type="fig"} and [2](#f2-grsb-2010-091){ref-type="fig"}). Relative message levels for ACC mRNA were decreased (*P* \< 0.05) compared to NONE for both oil treatments. At MED oil supplementation levels, FASN mRNA tended to be up-regulated (*P* = 0.08) compared to NONE. However as for expression levels of ACC and SCD, FASN message decreased (*P* = 0.05) in HI compared to NONE. Among the lipogenic genes examined, only LPL message levels increased (*P* \< 0.05) by 3.9-fold in the HI treatment compared to NONE. At MED corn oil supplementation levels, LPL expression was down-regulated (*P* \< 0.05) compared to NONE.

The relative expression of transcription factors or co-activators thought to be involved in fat metabolism[@b12-grsb-2010-091] is presented in [Table 4](#t4-grsb-2010-091){ref-type="table"}. At MED supplementation level, the transcription factors of PPARγ, SREBP1, and STAT5 mRNA were down-regulated (*P* \< 0.05) compared to NONE. Message levels of C/EBPα and NF-Y did not differ (*P* \> 0.05) in MED group compared to NONE. At the HI corn oil level, PPARγ, STAT5 and SREBP-1 mRNA expression did not differ (*P* \> 0.05) compared to NONE. C/EBPα mRNA expression level tended (*P* = 0.06) to be reduced with HI compared to NONE. NF-Y and Spot-14 message levels were up-regulated (*P* \< 0.05) 1.7- and 3-fold, respectively, for HI group compared to NONE.

The correspondence between the two methods of gene expression analysis is presented in [Table 5](#t5-grsb-2010-091){ref-type="table"}. Four out of eight genes showed similar expression changes. There was agreement between microarray and qPCR for FASN, LPL, SCD, and SREBP in which significance and direction were similar between the two platforms. In contrast, there was a lack of agreement between the platforms for changes in ACC, PPARγ, C/EBPα, and STAT5 mRNA expression with oil supplementation. For ACC, mRNA expression was unchanged (*P* \> 0.05) using microarray analysis but was downregulated (*P* \< 0.05) with qPCR analysis. For PPARγ and C/EBPα, mRNA expression was up-regulated (*P* \< 0.05) in microarray analysis but unchanged (*P* \> 0.05) according to qPCR. For STAT5, message levels were down-regulated (*P* \< 0.05) for microarray but unchanged (*P* \> 0.05) according to qPCR.

Discussion
==========

Extraction of high quality RNA from fatty tissues is especially difficult compared to other tissues. Utilization of typical extraction methods, ie, TRIzol procedure, for fatty tissues results in poor RNA yields, unacceptable RNA quality and DNA carryover.[@b13-grsb-2010-091] Thus, extracted RNA from TRIzol procedure is unacceptable for use in qPCR or microarray without additional purification procedures that remove protein and/or DNA contaminants not effectively removed due to high lipid levels in adipose tissue. In addition, the low yield of RNA from fatty tissues requires the use of larger tissue samples sizes to purify adequate quantities for gene expression analyses including northern blotting, protection assays, qPCR, and microarray analyses. Therefore, we developed a new protocol for the extraction of high quality RNA from high fat, subcutaneous adipose tissues utilizing the chemistry of two commercially available RNA purification reagants. This protocol produced tcRNA samples with high quality (260/280 ratios of \> 1.8) and adequate RNA yield (avg = 32 μg/g adipose tissue with range of 15--50 ug/g).

Lipogenic gene expression was altered due to dietary lipid in this study. Stearoyl-CoA desaturase catalyzes the rate-limiting step in monounsaturated fatty acid (MUFA) synthesis and conversion of trans-11 vaccenic acid (TVA) to cis-9 trans-11 conjugated linoleic acid (CLA), a potent anticarcinogen found in ruminant products.[@b14-grsb-2010-091] Oil supplementation level influenced the mRNA expression of SCD in subcutaneous adipose tissues. At MED levels, SCD mRNA was up-regulated; however at HI levels, SCD mRNA was down-regulated. Because the majority of cis-9 trans-11 CLA is produced via desaturation by SCD (80%),[@b15-grsb-2010-091] the down-regulation of SCD mRNA expression with HI would result in a lower conversion of TVA to CLA even though dietary linoleic acid supply was increasing. Indeed, a curvilinear response in CLA concentration with increasing corn oil supplementation was identified.[@b9-grsb-2010-091] Similarly, Duckett et al (2009)[@b16-grsb-2010-091] and Waters et al (2009)[@b17-grsb-2010-091] also reported down-regulation of SCD expression in adipose tissue of steers supplemented with corn oil or soybean oil.

Research in rodents has shown that omega-6 supplementation *in vitro* or *in vivo* down regulated SCD-1 mRNA. Rodents have several SCD isoforms, with SCD-1 being highly expressed in lipogenic tissues. [@b18-grsb-2010-091] Jeffcoat and James (1978)[@b2-grsb-2010-091] found that SCD activity was diminished by 60% in the first 18 h after feeding a PUFA diet (corn oil) to rats. Addition of arachidonic acid to 3T3-L1 adipocytes in culture reduced SCD activity by 60% and SCD-1 mRNA by 80% within 6--12 h after treatment.[@b19-grsb-2010-091] Additional research *in vitro* showed that addition of individual PUFA (linoleic, linolenic and eicosapentaeinoic acid) also down-regulated SCD-1 mRNA; whereas, stearic and oleic acids did not alter SCD-1 mRNA level. Similarly, Ntambi (1992) found reductions in SCD-1 mRNA abundance after feeding triglycerides containing linoleic, linolenic and arachidonic acids but not with triglycerides containing palmitic, stearic or oleic acid compared to a fat-free diet. In the rodent studies, dietary PUFA supplementation was at higher levels (10% of diet) than in this study. Total dietary fatty acid content in this study was lower (HI = 8% of diet) than those in rodent studies (10%) but higher than recommended for optimal growth performance in high concentrate fed cattle (4%--6% of diet).[@b20-grsb-2010-091] In addition, dietary PUFA would be biohydrogenated in ruminant animals such that much smaller proportions of PUFA would reach the tissues and may explain the lower response in changes in gene expression to PUFA supplementation observed in this beef study versus rodent studies.

Both ACC and FASN are key enzymes regulating *de novo* fatty acid synthesis and palmitic acid production. These results indicate that at HI supplementation levels (8% fatty acids) both ACC and FASN were down regulated, which would result in lower *de novo* fatty acid synthesis and palmitic acid production. Indeed, tissue (L.M. and s.c.) concentrations of palmitic acid were lower in steers grazing endophyte free tall fescue with HI levels of oil supplementation.[@b9-grsb-2010-091] This reduction in palmitic acid content with oil supplementation was an interesting result from this research project as this fatty acid is considered to be hypercholesterolemic.[@b21-grsb-2010-091] Thus, oil supplementation appears to down-regulate *de novo* fatty acid synthesis to reduce the concentration of the end product, palmitic acid, a hypercholesterolemic fatty acid. Dietary polyunsaturated fatty acids (PUFA; both omega-6 and omega-3) are potent inhibitors of hepatic *de novo* lipogenesis in rodents.[@b2-grsb-2010-091]--[@b4-grsb-2010-091] Wilson et al (1990)[@b22-grsb-2010-091] showed that PUFA feeding to rats resulted in a dose-dependent reduction of hepatic fatty acid synthesis *in vivo*. Jeffcoat and James (1978)[@b2-grsb-2010-091] reported that supplementing corn oil to weanling rats at levels from 0.5% to 10% of diet (w/w) reduced FASN activity to about 30% of the level for a fat-free diet. Further studies showed diets rich in PUFA fed to adult and weanling rats reduced hepatic abundance of FASN by 2-fold[@b3-grsb-2010-091] and 5.8-fold[@b4-grsb-2010-091] *in vivo*.

Lipoprotein lipase (LPL) is the enzyme responsible for the uptake of dietary fatty acids. These results suggest that HI levels of corn oil supplementation up-regulate LPL expression to uptake greater amounts of available dietary fatty acids. Similarly, Waylan et al (2004)[@b23-grsb-2010-091] reported that feeding flaxseed at 5% of diet also increased gene expression of LPL in muscle tissues.

Morrison and Farmer (2000)[@b12-grsb-2010-091] proposed several transcription factors that are believed to be involved in fat metabolism and these were examined in this study. Our qPCR results show that STAT5 was downregulated at MED oil supplementation level but unchanged at HI oil supplementation level. Hogans and Stephens (2005)[@b24-grsb-2010-091] found that STAT5 directly represses the expression of FASN in adipocytes. These results agree with those in this study as STAT5 was down-regulated and FASN up-regulated at the MED oil supplementation level. SREBP-1 contains a sterol regulatory element (SRE) and PUFA supplementation in rodents down regulates this transcription factor in rodents[@b25-grsb-2010-091] and chickens.[@b26-grsb-2010-091] Current research shows that FASN[@b27-grsb-2010-091] and SCD[@b26-grsb-2010-091] promoters contains recognition sites for SREBP-1, upstream stimulatory factor, stimulatory protein 1, and NF-Y, which are involved in the regulation by PUFA. Teran-Garcia et al (2007)[@b27-grsb-2010-091] has shown PUFA decrease *in vivo* binding of NF-Y and SREBP-1c to the proximal promoter of hepatic FASN, Spot 14 and SCD. These results suggest that PUFA regulate the binding of NF-Y and SREBP-1c to coordinately target genes involved in lipid metabolism. Waters et al (2008)[@b17-grsb-2010-091] also observed a decreased expression of SREBP-1c and no change in PPARα with 4% soybean oil and 2% fish oil addition to high concentrate diet in steers. PPARγ and C/EBPα are transcription factors known to be involved in the differentiation of adipocytes. Data suggests that the majority of adipocyte differentiation in beef animals occurs prior to 8 month of age.[@b28-grsb-2010-091] In addition, accumulation of fat in older beef animals appears to be primarily due to hypertrophy of the fat cell instead of fat cell proliferation/differentiation.[@b1-grsb-2010-091] Taken with our current data, the low levels of PPARγ and C/EBPα would support little adipocyte proliferation and greater adipocyte hypertrophy occurring for lipid accumulation in these steers at the time of this study.

Spot-14 is a nuclear protein that is responsive to thyroid hormone (T~3~) and is involved in regulation of lipid synthesis in rat hepatocytes.[@b29-grsb-2010-091] The function of Spot-14 is unknown but a high correlation between fatty acid synthase (FASN) and Spot-14 indicate that it is involved in lipid metabolism.[@b3-grsb-2010-091] Zhu et al[@b30-grsb-2010-091] suggested that Spot-14 protein is involved in allosteric regulation of *de novo* fatty acid synthesis. Zhu et al[@b1-grsb-2010-091] has also shown that Spot-14 knock-out mice had increased hepatic lipogenesis, which shows that Spot-14 is not required but may alter lipogenic rates. In this study, HI level of oil supplementation increased Spot-14 expression and tended to decrease FASN expression, which resulted in a reduction of palmitic acid, a product of *de novo* lipogenesis, in s.c. adipose tissues.

The correspondence between microarray and qRT-PCR for four lipogenic genes and four transcription factors of interest was within the acceptable limits. Joseph et al[@b32-grsb-2010-091] also reported a similar agreement among the two gene expression platforms. Hausman et al[@b33-grsb-2010-091] reported significant correlations and linear regression between microarray and RT-PCR; however they noticed that changes related to animal age were only detected by RT-PCR and not by microarray analysis. Even though both the platforms allow assay of gene expression, microarrays are infamous for their associated error both as technical and biological error as well as their sequence-specific effects which makes expression prediction difficult for at least some of the genes.[@b34-grsb-2010-091] This difference in the correspondence across the two platforms might also be accounted due to the pooling of RNA for microarray analysis where as individual RNA samples were used for qRT-PCR. Also, the qRT-PCR primer is designed based on the sequence database, which is derived from multiple sequence alignment of ESTs. As a result there is a high chance that Affymetrix may target one gene, while the sequence database may infact represent an entire gene family with less specificity and therefore will interrogate neither the Affymetrix gene nor the database gene and thus give results that differ from both platforms.[@b35-grsb-2010-091]

The results from this study show that the MED level of oil supplementation (4.94% total fatty acids in diet) up-regulates gene expression of key lipogenic enzymes (FASN, SCD, or LPL) but that as oil supplementation reaches HI level (7.99% total fatty acids in diet) genes encoding lipogenic enzymes responsible for *de novo* fatty acid synthesis and MUFA synthesis are down-regulated. These results agree with changes in tissue fatty acid composition in which palmitic (C16:0) acid concentration, a product of *de novo* fatty acid synthesis, and CLA cis-9 trans-11 isomer, a product of desaturation, were reduced with the highest level of oil supplementation.

Supplementary Material
======================

###### 

Additional genes associated with fatty acid synthesis and metabolism that were identified to be differentially expressed in subcutaneous adipose tissues from steers supplemented with HI corn oil levels compared to NONE.

  **Gene**                                                                                                    **Gene symbol**   **FDR corrected *P*-value**   **Pathway involved**
  ----------------------------------------------------------------------------------------------------------- ----------------- ----------------------------- ----------------------------
  Malic enzyme 3, NADP(+)-dependent, mitochondrial isoform 2                                                  ME3               \<0.01                        Esterification pathway
  Malate dehydrogenase 2, mitochondrial                                                                       MDH2              \<0.01                        Esterification pathway
  Pyruvate dehydrogenase phosphatase                                                                          PDP               0.01                          Esterification pathway
  Pyruvate dehydrogenase kinase isoform 4                                                                     PDK4              \<0.01                        Esterification pathway
  Pyruvate dehydrogenase (lipoamide) beta                                                                     PDHB              \<0.01                        Esterification pathway
  Adipose differentiation-related protein                                                                     ADFP              \<0.01                        Esterification pathway
  Propionyl-CoA carboxylase beta                                                                              PCCB              \<0.01                        Proprionyl-CoA metabolism
  Methylmalonyl-coA mutase                                                                                    MCM               \<0.01                        Proprionyl-CoA metabolism
  Methylmalonyl-coA Epimerase                                                                                 MCE               0.04                          Proprionyl-CoA metabolism
  Pyruvate Kinase                                                                                             PK                \<0.01                        Proprionyl-CoA metabolism
  Succinate dehydrogenase complex, subunit C, integral membrane protein                                       SDHC              \<0.01                        Proprionyl-CoA metabolism
  Succinate dehydrogenase complex, subunit D, integral membrane protein                                       SDHD              \<0.01                        Proprionyl-CoA metabolism
  Aconitase 2, mitochondrial                                                                                  ACO2              \<0.01                        Proprionyl-CoA metabolism
  Phosphoenolpyruvate Carboxykinase 2 (mitochondrial)                                                         PCK2              \<0.01                        Glycolysis/gluconeogenesis
  Fructose 2,6-bisphosphatase                                                                                 Fru-2,6-*P*~2~    \<0.01                        Glycolysis/gluconeogenesis
  Glucose-6-phosphate dehydrogenase                                                                           G6PD              0.027                         Pentose pathway
  6-Phosphogluconate dehydrogenase                                                                            6PGDH             \<0.01                        Pentose pathway
  Sterol regulatory element binding protein cleavage-activating protein (SREBP cleavage-activating protein)   SCAP              0.02                          Pentose pathway
  Superoxide Dismutase 2, Mitochondrial                                                                       SOD2              \<0.01                        Pentose pathway
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###### 

Protocol developed for high quality RNA isolation from high fat, subcutaneous adipose tissues.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Homogenize 1 g adipose tissue in 5 mL of cold TRIzol solution for 30s.Centrifuge at 2600 x *g* for 30 min at 2 °C.Remove excess fat layer.Transfer cleared homogenate to clean tube.Incubate for 5 min. at 22 °C.Add 0.2 ml of chloroform per ml of TRIzol reagent.Cap tubes and shake vigorously for 15s.Incubate for 2--3 min. at 22 °C.Centrifuge at 2600 x *g* for 30 min.Transfer clear aqueous layer to clean tube.Add 0.57x the amount of aqueous layer in isopropanol to the tube and mix.Load onto PureYield™ RNA Midiprep System clearing column (Promega).Elute under vacuum.Wash with 20 mL RNA wash solution under vacuum.Place column in clean 50 mL tube and 1 ml of RNase-free water to top of column.Centrifuge at 2000 x *g* for 3 min.Quantify RNA. Approximate yield of 35 ug/g of subcutaneous bovine adipose tissue with 260/280 ratios of \>1.8 using this method.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Primer sequences (5' to 3') for quantitative real-time PCR.

  **Gene**   **Forward**            **Reverse**            **Efficiency**
  ---------- ---------------------- ---------------------- ----------------
  β-Actin    CTCTTCCAGCCTTCCTTCCT   GGGCAGTGATCTCTTTCTGC   0.85
  ACC        AGCTGAATTTTCGCAGCAAT   GGTTTTCTCCCCAGGAAAAG   1.07
  C/EBPα     TGGACAAGAACAGCAACGAG   GGTCATTGTCACTGGTCAGC   0.95
  FASN       GCATCGCTGGCTACTCCTAC   GTGTAGGCCATCACGAAGGT   0.93
  GAPDH      GGGTCATCATCTCTGCACCT   GGTCATAAGTCCCTCCACGA   0.93
  LPL        GGGTTTTGAGCAAGGGTACA   GCCACAATGACCTTTCCAGT   0.97
  NF-Y       ATGCAGGATCCAAATCAAGC   AAAAGGGCAGAATGTGATCG   1.05
  PPARγ      AGGATGGGGTCCTCATATCC   GCGTTGAACTTCACAGCAAA   0.86
  SCD        TTATTCCGTTATGCCCTTGG   GGTAGTTGTGGAAGCCCTCA   0.95
  Spot14     CCTCACCCATCTTACCCTGA   CAAGCTAGCAAACTGCACCA   1.05
  SREBP1     CTGGAGAAGCTGGACTGAGG   GCTTTCCCAAGACTCAGCAC   0.86
  STAT5      TGGGAAAGATGGGAACTGAG   ACCAACAAGTCTGGGTCAGG   1.00

###### 

Microarray results for gene expression in subcutaneous adipose tissues from steers supplemented with HI corn oil levels compared to NONE.[\*](#tfn2-grsb-2010-091){ref-type="table-fn"}

  **Gene product**                                                     **Gene symbol**   ***P*-value**   **Fold-change**   **Up or down regulated**
  -------------------------------------------------------------------- ----------------- --------------- ----------------- --------------------------
  **Genes involved in lipogenesis**                                                                                        
  Acetyl-CoA carboxylase                                               ACC               0.17                              
  Carnitine palmitoyltransferase II                                    CPT2              \<0.01          2.63              Down
  Fatty acid synthase                                                  FASN              \<0.01          2.73              Down
  Isocitrate dehyrogenase 2                                            IDH2              0.06            1.52              Up
  Isocitrate dehydrogenase 1                                           IDH1              \<0.01          6.81              Down
  Lipase, hormone-sensitive                                            HSL               \<0.01          7.46              Down
  Lipoprotein lipase                                                   LPL               \<0.01          3.70              Up
  Long-chain fatty acyl elongase                                       ELOVL             0.04            4.96              Up
  Stearoyl-CoA desaturase                                              SCD               0.001           7.78              Down
  Glycerol-3-phosphate acyltransferase mitochondrial                   GPAT              \<0.01          24.96             Down
  Putative diacylglycerol O-acyltransferase                            DGAT2             \<0.01          5.40              Down
  1-Acylglycerol-3-phosphate O-acyltransferase 1                       AGPAT1            \<0.01          7.96              Down
  Solute carrier family 25 (citrate transporter)                       SLC25 A           0.002           3.31              Down
  **Transcription factors/co-activators involved in fat metabolism**                                                       
  CCAAT/enhancer binding protein-α                                     C/EBPα            \<0.01          14.31             Up
  CCAAT/enhancer binding protein-Δ                                     C/EBPΔ            \<0.01          4.37              Up
  Peroxisome proliferators activated receptor γ                        PPAR-γ            \<0.01          34.99             Up
  Signal transducer and activator of transcription 5B                  STAT5b            \<0.01          2.54              Down
  Sterol regulatory element binding protein                            SREBP             0.23                              

**Note:**

If the FDR corrected *P*-value is not significant then the fold-change and directionality of the expression of those genes are not provided.

###### 

qPCR results for differential gene expression in subcutaneous adipose tissues from steers supplemented with MED and HI corn oil levels compared to NONE.

  **Corn oil treatment level**                          **MED**   **HI**                               
  ----------------------------------------------------- --------- -------- ------ ------ ------ ------ ------
  Acetyl-CoA carboxylase                                ACC       0.03     1.56   Down   0.01   1.87   Down
  Fatty acid synthase                                   FASN      0.08     1.39   Up     0.04   1.36   Down
  Lipoprotein lipase                                    LPL       0.02     1.70   Down   0.02   3.9    Up
  Stearoyl-CoA desaturase                               SCD       0.01     1.44   Up     0.02   1.20   Down
  CCAAT/enhancer binding protein-α                      C/EBPα    0.13     1.30   Down   0.06   1.63   Down
  Nuclear factor Y                                      NF-Y      0.17     1.16   Down   0.02   1.74   Up
  Peroxisome proliferators activated receptor γ         PPARγ     0.01     2.60   Down   0.42   1.12   Down
  Signal transducer and activator of transcription 5B   STAT5b    0.03     2.75   Down   0.67   1.12   Down
  Spot-14                                               Spot-14   0.08     1.12   Down   0.01   3.08   Up
  Sterol regulatory element binding protein             SREBP     0.01     1.78   Down   0.26   1.13   Up

###### 

Comparison among microarray and qPCR results for HI compared to NONE.[\*](#tfn3-grsb-2010-091){ref-type="table-fn"}

  **Gene Symbol**   **Microarray*P*-value**                                          **qPCR*P*-value**
  ----------------- ---------------------------------------------------------------- ---------------------------------------------------------------
  ACC               0.167                                                            \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (1.87) ⇓
  FASN              \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (2.73) ⇓    0.04[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (1.36) ⇓
  LPL               \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (3.70) ⇑    0.02[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (1.58) ⇑
  SCD               \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (7.78) ⇓    0.02[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (1.20) ⇓
  PPARγ             \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (34.99) ⇑   0.420
  SREBP             0.229                                                            0.26
  STAT5             \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (2.54) ⇓    0.67 (1.12) ⇓
  C/EBPα            \<0.01[\*](#tfn3-grsb-2010-091){ref-type="table-fn"} (14.31) ⇑   0.06

Note:

Indicates statistical significance; Fold change is shown with in the brackets; If the p-value is not statistically significant then the fold-change and direction of expression changes of those genes are not shown.
